These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 9614834

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Leprosy reactions: humoral and cellular immune responses to M. leprae, 65kDa, 28kDa, and 18 kDa antigens.
    Mohanty KK, Joshi B, Katoch K, Sengupta U.
    Int J Lepr Other Mycobact Dis; 2004 Jun; 72(2):149-58. PubMed ID: 15301588
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [The collateral effects of prolonged corticosteroid therapy].
    Genova R.
    Minerva Pediatr; 1969 Oct 27; 21(43):2026-38. PubMed ID: 4326808
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Side-effects of corticosteroid agents.
    Seale JP, Compton MR.
    Med J Aust; 1986 Feb 03; 144(3):139-42. PubMed ID: 3511355
    [Abstract] [Full Text] [Related]

  • 8. Monitoring the effects of preventive therapy in the Federated States of Micronesia.
    Cho SN, Walsh GP, Brennan PJ.
    Int J Lepr Other Mycobact Dis; 1999 Dec 03; 67(4 Suppl):S19-22. PubMed ID: 10700932
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Side-effects of corticosteroid therapy (author's transl)].
    Karl HJ.
    MMW Munch Med Wochenschr; 1980 Aug 29; 122(35):1191-4. PubMed ID: 6780800
    [Abstract] [Full Text] [Related]

  • 12. Assessment of anti-PGL-I as a prognostic marker of leprosy reaction.
    Stefani MM, Martelli CM, Morais-Neto OL, Martelli P, Costa MB, de Andrade AL.
    Int J Lepr Other Mycobact Dis; 1998 Sep 29; 66(3):356-64. PubMed ID: 9934362
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Antibody response to phenolic glycolipid I and Mycobacterium w antigens and its relation to bacterial load in M. leprae-infected mice and leprosy patients.
    Moudgil KD, Gupta SK, Naraynan PR, Srivastava LM, Mishra RS, Talwar GP.
    Clin Exp Immunol; 1989 Nov 29; 78(2):214-8. PubMed ID: 12412751
    [Abstract] [Full Text] [Related]

  • 18. [Management of complications of steroid therapy].
    Hara M, Sasaki H.
    Nihon Rinsho; 1984 Nov 29; 42(11):2516-9. PubMed ID: 6442370
    [No Abstract] [Full Text] [Related]

  • 19. Rational combination of peptides derived from different Mycobacterium leprae proteins improves sensitivity for immunodiagnosis of M. leprae infection.
    Geluk A, van der Ploeg J, Teles RO, Franken KL, Prins C, Drijfhout JW, Sarno EN, Sampaio EP, Ottenhoff TH.
    Clin Vaccine Immunol; 2008 Mar 29; 15(3):522-33. PubMed ID: 18199740
    [Abstract] [Full Text] [Related]

  • 20. Type 1 reaction in leprosy: a model for a better understanding of tissue immunity under an immunopathological condition.
    Andrade PR, Pinheiro RO, Sales AM, Illarramendi X, Barbosa MG, Moraes MO, Jardim MR, Nery JA, Sampaio EP, Sarno EN.
    Expert Rev Clin Immunol; 2015 Mar 29; 11(3):391-407. PubMed ID: 25666357
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.